top of page

Fibrocor Therapeutics

Human-derived, disease-relevant targets for Kidney disease

About

Fibrocor Therapeutics is a biotech startup specializing in early-stage treatments for fibrotic diseases, bringing potentiallu life-changing therapies to patients with few existing options.

INDUSTRY

Life Sciences

William Newsome

President and CEO

Marianna Saporita

Senior Director

Fibrocor Therapeutics

Publications

BIC Presents: Prospecting for Biotech - Podcast

BIC Stage 2 Accelerator - Meet Fibrocor - Video

bottom of page